# Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer

> **NCT03716245** · NA · COMPLETED · sponsor: **Xinhong Wu, PhD** · enrollment: 180 (actual)

## Conditions studied

- Breast Cancer Stage III

## Interventions

- **PROCEDURE:** supraclavicular lymph node dissection
- **RADIATION:** supraclavicular area radiotherapy

## Key facts

- **NCT ID:** NCT03716245
- **Lead sponsor:** Xinhong Wu, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-27
- **Primary completion:** 2024-01-20
- **Final completion:** 2024-01-20
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03716245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03716245, "Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03716245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*